It can act as either a tumor suppressor, like in lung cancer, where it suppresses tumor growth by inducing G1 arrest via cyclin-dependent kinase inhibitor (CDKI) p21, or as an oncogene, like in breast cancer, promoting cell survival and apoptosis resistance [11]. Here, CDKN3 is linked to neoplasm.